Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03326674
Status:
TERMINATED
Last Update Posted:
2021-07-30
First Post:
2017-10-13
Brief Title:
Tesetaxel Plus Reduced Dose of Capecitabine vs Capecitabine in HER2 Negative HR Positive LAMBC
Sponsor:
Odonate Therapeutics Inc
Organization:
Odonate Therapeutics Inc
Organization Data
Organization:
Odonate Therapeutics Inc
Class:
INDUSTRY
Study ID:
ODO-TE-B301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Odonate Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None